Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000649218 | SCV000771043 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001577293 | SCV001804646 | likely benign | not provided | 2020-04-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002343341 | SCV002649080 | likely benign | Cardiovascular phenotype | 2020-01-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV003150323 | SCV003838435 | likely benign | Cardiomyopathy | 2021-09-28 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001796166 | SCV002034559 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001577293 | SCV002036766 | likely benign | not provided | no assertion criteria provided | clinical testing |